Target intelligence / Profile preview

Hard tissue barrier formation

Molecular classification
Biological process
01

Overview

Hard tissue barrier formation is a physiological repair process characterized by the deposition of a mineralized matrix, typically tertiary dentin, to seal and protect the dental pulp from external stimuli (PubMed: 20197136). This process is not a single molecular target but rather a coordinated biological response involving the recruitment and differentiation of dental pulp stem cells (DPSCs) into odontoblast-like cells (PubMed: 21411358). Therapeutic intervention in this area focuses on the use of bioactive materials, such as calcium silicate-based cements (e.g., Mineral Trioxide Aggregate), which create an alkaline environment and release calcium ions to trigger endogenous signaling pathways like the BMP/Smad and MAPK pathways (PubMed: 25635963). The successful induction of a hard tissue barrier is the primary clinical endpoint for vital pulp therapies, aiming to preserve the natural tooth structure and vitality (StatPearls: NBK551626). Challenges in this field include ensuring the structural integrity of the formed barrier, as 'tunnel defects' can allow for bacterial microleakage and subsequent pulp failure (PubMed: 10403123).

Other names
Dentin bridge formationMineralized barrier formationApexificationCalcific bridge formationInduced hard tissue barrier
02

Mechanism of action

Induction of an alkaline environment and release of calcium ions, which stimulate the expression of bone morphogenetic proteins (BMPs) and alkaline phosphatase, leading to the differentiation of dental pulp stem cells into odontoblast-like cells that secrete a mineralized matrix (PubMed: 25635963).

03

Biological functions

BiomineralizationTissue repairOdontoblast differentiationDentinogenesis
04

Disease associations

PulpitisDental cariesDental traumaOpen apex
05

Safety considerations

Tunnel defects in the mineralized barrierPulp necrosisChronic pulp inflammationMaterial-induced cytotoxicity
06

Interacting drugs

Mineral trioxide aggregate

3 more in the full profile.

07

Biomarkers

Alkaline phosphatase (ALP)Dentin sialophosphoprotein (DSPP)Dentin matrix acidic phosphoprotein 1 (DMP1)Osteocalcin

Beyond the preview

Go deeper on Hard tissue barrier formation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hard tissue barrier formation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call